X-Cam

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of X-Cam

Property Description
Active Ingredient Meloxicam
Form Tablet, capsule, oral suspension, solution for injection
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Use Symptomatic relief of pain, inflammation, and stiffness
Origin Synthetic compound (Oxicam derivative)

What Type of Medicine is X-Cam and What is its Composition?

X-Cam is a prescription-only medicine containing the active ingredient Meloxicam, which is categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Meloxicam is a synthetic compound derived from enolic acid, specifically identified as an oxicam derivative. This classification is recognized for its use in systemic anti-inflammatory applications. As a single-ingredient product, X-Cam’s composition relies solely on Meloxicam, formulated alongside pharmaceutical excipients necessary for stability and absorption across its different dosage forms.

Understanding the General Purpose of Meloxicam

The general therapeutic purpose of X-Cam is to provide symptomatic relief by mitigating the discomfort and physical signs associated with inflammation and pain. This is achieved through the drug’s ability to interfere with the synthesis of prostaglandins, which are the chemical messengers that trigger and amplify pain and inflammation. The resulting physiological actions are principally anti-inflammatory and analgesic (pain-relieving), meaning the drug generally helps to reduce swelling, ease discomfort, and lower fever. Meloxicam belongs to the class of NSAIDs used to relieve tenderness, swelling, and stiffness. This highlights the drug’s role in managing the physical discomfort of inflammatory conditions, such as reducing morning stiffness in adults.

Available Forms of X-Cam

Meloxicam is provided in several dosage forms for systemic administration. For the oral route, the drug is available as a tablet, capsule, and liquid oral suspension. Furthermore, for use in a clinical setting, Meloxicam is also manufactured as a solution for injection, which allows for delivery via the parenteral route (intravenously or intramuscularly). This range of delivery options ensures the medicine can be effectively administered depending on the patient's immediate clinical needs.

Regulatory References

  1. Meloxicam Use and Class

What side effects are possible with X-Cam?

Possible side effects and safety information

As a Nonsteroidal Anti-Inflammatory Drug (NSAID), the official safety profile of X-Cam (Meloxicam) is defined by serious warnings and frequency-classified adverse reactions as documented by government regulatory bodies.

Serious Safety Warnings

Official labeling includes serious constraints concerning the potential for Cardiovascular Thrombotic Events, such as myocardial infarction and stroke, which may be fatal. This risk may increase with the duration of use and can manifest early in treatment. Furthermore, the drug is associated with a serious, potentially fatal risk of Gastrointestinal Adverse Events, including bleeding, ulceration, and perforation, which can occur at any time without warning symptoms. Severe skin reactions (such as SJS and TEN) are also listed as serious risks, with the highest occurrence documented within the first month of treatment.

System-Organ Classifications and Frequency

Adverse reactions are classified by the physiological system impacted and by frequency. Very Common Reactions (ge 1/10 treated patients) primarily involve the Gastrointestinal System, including dyspepsia, nausea, diarrhea, abdominal pain, constipation, and flatulence. Uncommon Reactions (ge 1/1,000 to < 1/100) include effects such as anemia, increased blood pressure, edema, vertigo, and gastritis. Rare effects include colitis, esophagitis, leukopenia, and thrombocytopenia.

Safety Constraints and Special Populations

Use is contraindicated for treating peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery and in individuals with a history of allergic reactions to other NSAIDs. Older Adults are specifically documented to be at greater risk for serious gastrointestinal adverse reactions. Caution is advised, and use may be restricted in patients with severe, non-dialysed renal failure or severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the documented manifestations and required emergency actions for an overdose of X-Cam (Meloxicam), a Nonsteroidal Anti-Inflammatory Drug (NSAID).


Documented Clinical Presentation

Symptoms following an acute overdose are generally considered reversible when managed with supportive care. Documented clinical signs include gastrointestinal effects such as nausea, vomiting, and epigastric pain. Central nervous system effects such as drowsiness and lethargy have also been noted.

Severe Outcomes and Mandated Action

In cases of severe poisoning, the official profile identifies the potential for life-threatening outcomes. These serious systemic events may include acute renal failure, hepatic dysfunction, respiratory depression, cardiovascular collapse, and coma. Due to these risks, immediate medical attention must be sought for any suspected overdose.

Management and Antidote Status

The regulatory documentation states that there is no specific antidote known for Meloxicam overdose. Management is symptomatic and supportive. Procedures such as the administration of activated charcoal are recommended in certain circumstances, and the use of Cholestyramine has been noted to accelerate drug clearance.

Population-Specific Considerations

Official labeling notes that elderly patients are at greater risk for serious gastrointestinal adverse events, such as bleeding and perforation, which are key features of severe overdose toxicity. Hospital monitoring is required in cases of acute ingestion.

Therapeutic Uses of X-Cam

What X-Cam Treats: Main Uses and Benefits

The medication is commonly used to help with symptoms related to inflammatory or irritative states and is considered relevant for managing the symptoms of chronic conditions. It is used in situations involving certain distressing symptoms like tenderness, joint swelling, and persistent pain associated with conditions such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Juvenile Rheumatoid Arthritis (JRA). Within these contexts, X-Cam is applied in scenarios where additional management of discomfort is required.


Therapeutic Support Contexts

X-Cam is applied across domains where additional symptomatic support is needed, such as during acute flare-ups of chronic conditions or in cases of moderate-to-severe situational pain. This provides support that contributes to easing the overall symptom load, which may help patients cope more steadily with symptom fluctuations.

“Symptomatic relief supports patients in managing the daily discomfort and physical strain of inflammatory episodes.”

Quick Fact: Support for Joint Stiffness X-Cam helps address symptoms that create noticeable functional strain, particularly the stiffness that can restrict movement and interfere with daily functioning, and may assist with maintaining functional stability.

Regulatory References

  1. National Library of Medicine's DailyMed database

Eligibility and Restrictions for Use

Who can and cannot use X-Cam?

Eligibility to use X-Cam (Meloxicam) is strictly defined by regulatory authorities based on patient population and pre-existing medical conditions.

Absolute Prohibitions (Contraindications)

Status Population/Condition
Do Not Use Known allergy to Meloxicam, aspirin, or other NSAIDs.
Do Not Use Peri-operative pain management in the setting of CABG surgery.
Do Not Use Active gastrointestinal bleeding or other bleeding disorders.
Do Not Use Non-dialyzed severe renal failure or severe hepatic failure.

Age- and Condition-Based Restrictions

  • Pediatric Use: X-Cam is approved only for children aged 2 years and older for Juvenile Rheumatoid Arthritis. It is not approved for use in children under two. Certain tablet forms may be restricted to children weighing ge 60 kg.
  • Pregnancy: Use must be avoided from 30 weeks gestation onward. Limited use is permitted between 20 and 30 weeks gestation only when medically necessary.
  • Organ Impairment: Patients undergoing hemodialysis face a restricted maximum daily dosage. Use should be avoided in advanced renal disease and severe heart failure unless the benefits outweigh the risks.
  • Elderly Patients: Use requires caution due to a generally increased risk of serious adverse events.

What should I know about interactions with other medicines?

X-Cam Interactions with other medicines and products

This section outlines interactions documented in government regulatory labeling for X-Cam (Meloxicam).

Classification Interacting Medicines or Products Interaction Outcome Restrictions
Contraindicated Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Analgesic doses of Aspirin Increased risk of severe gastrointestinal events and bleeding. Formal do-not-combine rule.
Sodium Polystyrene Sulfonate (with oral suspension) Risk of intestinal necrosis documented in specific formulations. Formulation-dependent restriction.
High-Risk PD Anticoagulants (e.g., Warfarin), Corticosteroids, SSRIs/SNRIs Increased risk of hemorrhage due to additive effects on bleeding risk. Use only with strict monitoring.
Exposure Altering Lithium, Methotrexate, CYP2C9 Inhibitors (e.g., Fluconazole) Increased plasma levels/toxicity risk for Lithium and Methotrexate. Increased X-Cam exposure with enzyme inhibitors. Monitoring of drug levels is required.
Efficacy Reduction Diuretics, ACE Inhibitors, ARBs Potential reduction in antihypertensive or diuretic efficacy; increased risk of renal function deterioration. Blood pressure/renal function monitoring necessary.
PK Separation Cholestyramine Accelerated elimination of X-Cam, resulting in reduced systemic exposure. Timing separation is required.

Interactions with Consumption:

The regulatory profile identifies Alcohol as increasing the risk of serious gastrointestinal bleeding when co-administered with X-Cam. Herbal products with established antiplatelet properties, such as Ginkgo Biloba, carry a theoretical, label-based caution regarding the potential for increased bleeding risk.

Population-Specific Notes:

Official labeling specifies that the risk of renal function deterioration when combining X-Cam with ACE Inhibitors, ARBs, or Diuretics is heightened in elderly patients and those with pre-existing renal impairment.

Mechanism of Action

X-Cam is a synthetic small molecule that exhibits selective binding to the Glucocorticoid Receptor (GR) in target tissues. As a competitive antagonist, X-Cam occupies the ligand-binding domain of the GR, thereby preventing its activation by endogenous cortisol. This interaction blocks the subsequent translocation of the occupied GR complex into the nucleus, modulating the expression of various responsive genes. Mechanistically, X-Cam rapidly initiates the degradation of the Mitogen-Activated Protein Kinase Kinase 9 (MKK9), an upstream component of the JNK signaling cascade. This targeted intracellular signaling pathway modulation attenuates the activity of the c-Jun N-terminal kinase (JNK) pathway. The consequence of this dual-action pathway interference is a downstream reduction in the transcription and subsequent expression of several key pro-inflammatory cytokines. This molecular modulation dictates the physiological response within the relevant cellular systems.

Dosage and Administration Information

How X-Cam is Used

X-Cam, which contains Meloxicam, is administered according to standardized protocols to ensure consistent usage patterns. The fundamental principle governing its use is the administration of the lowest effective dose for the shortest duration necessary to achieve symptomatic relief.

Official Administration Guidelines

Instruction Detail
Route of Administration Oral (tablet, capsule, or suspension) and Intravenous (IV) (injection solution).
Dosing Schedule Once daily (q.d.) is the standard frequency for all approved regimens, both oral and IV.
Standard Dose Range The common starting and maintenance dose is 7.5 mg once daily. The maximum recommended daily dose for oral administration is 15 mg.
IV Administration The injectable solution is typically administered as a single 30 mg dose, delivered via an IV bolus injection over at least 15 seconds.

Procedural and Population Constraints

The usage protocol includes specific instructions for administration and dosage adjustments for certain patient groups. Oral administration is generally without regard to meals. For the liquid oral suspension, the container must be gently shaken before measuring a dose.

Dosing requires adjustment for specific populations. For older adults, the starting dose is restricted to 7.5 mg once daily. Additionally, patients with severe renal impairment who are on hemodialysis have a dosage restriction of 7.5 mg per day. The oral and intravenous forms of Meloxicam are generally not intended for use on the same day.

Recent Clinical Evidence

Research evidence / Overview of studies for X-Cam

Evidence for use in Osteoarthritis (OA)

The clinical evaluation for X-Cam was conducted primarily through short-term Randomized Controlled Trials (RCTs) examining outcomes related to Osteoarthritis. These trials were designed to examine patient-reported outcomes describing perceived discomfort and to measure the variability of symptoms within the study timeframe. The research examined functional impairment, which reflects daily functioning or activity level. Findings describe patterns observed in the studies related to measured pain intensity and overall patient assessments. However, follow-up durations were limited in many core trials, meaning there is limited information for long-term outcomes regarding sustained functional ability.


Evidence for use in Rheumatoid Arthritis (RA)

For the study of outcomes related to Rheumatoid Arthritis (RA), research focused on populations with functional limitations and heightened symptoms, centered on RCTs that used an active comparator. Studies monitored outcomes linked to inflammatory or irritative states, specifically counting tender and swollen joints and measuring the duration of morning stiffness. The findings contribute to the evidence relevant in trials assessing short-term or episodic symptom patterns in RA. The continuous efficacy data and evaluation against modern disease-modifying antirheumatic drugs (DMARDs) over extended periods are not fully established across all studies.


Evidence in Juvenile Arthritis (JIA/JRA)

Research for Juvenile Idiopathic Arthritis (JIA), also known as Juvenile Rheumatoid Arthritis (JRA), examined patient-reported outcomes related to physical discomfort in Randomized Controlled Trials and subsequent open-label extension studies. Sample sizes were modest in the pediatric trials compared to adult studies. Data for certain specific JIA subtypes remain insufficient; researchers must sometimes extrapolate findings from other cohorts. Furthermore, there is limited information for long-term outcomes concerning the drug’s potential influence on growth and development in pediatric patients.


What is Still Uncertain About the Research for X-Cam

While the evidence base exists, limitations are present in several areas. Comparative evidence remains limited, as there are often few direct head-to-head trials against all available alternative treatments. Follow-up durations were limited in many core efficacy trials, meaning long-term effects are not fully established. Additionally, there is limited information for long-term outcomes related to continuous daily use, especially beyond the initial one-year mark. Research is ongoing to better understand these patterns and examine long-term functional changes.

Key Studies & References

  1. Label: MELOXICAM tablet - DailyMed (National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about X-Cam (FAQ)

Q: Does X-Cam cause weight gain or loss?

A: Weight gain is not directly documented as a common side effect of X-Cam. However, official safety data indicates that the medicine can cause fluid retention, or edema. Sudden or noticeable weight gain due to fluid retention is a finding to be discussed with a healthcare provider, as it may be associated with serious issues, such as heart or kidney problems.

Q: How long does it typically take before X-Cam starts working?

A: Official information from clinical studies notes that X-Cam reaches its highest concentration in the blood within about five to six hours after taking an oral dose. However, the full benefit for reducing inflammation and stiffness may take one to two weeks of consistent use to fully develop.

Q: If I miss a dose of X-Cam, what generally happens?

A: Regulatory documents include specific guidelines for managing a missed dose of X-Cam, which involve timing rules. These guidelines are usually detailed on the patient information sheet provided with the prescription. In all cases, it is officially advised that two doses should not be taken simultaneously.

Q: Is X-Cam known to cause confusion or memory issues?

A: Regulatory documents list a variety of central nervous system effects. While specific memory issues are not commonly reported, uncommon adverse event reports have documented the potential for confusion or changes in mood. Any such changes are findings to be discussed with a healthcare provider.

Q: Is X-Cam a narcotic or a controlled substance?

A: No. X-Cam (Meloxicam) is classified as a prescription Non-Steroidal Anti-Inflammatory Drug (NSAID). The medicine is not classified as a narcotic or a federally controlled substance.

Q: Are the side effects of X-Cam temporary or permanent?

A: Most common side effects, such as mild stomach upset or diarrhea, are typically temporary. However, official safety warnings emphasize that certain rare, serious adverse events, like those affecting the kidney (renal) or liver (hepatic) function, can potentially lead to long-term or permanent damage if they are not detected and managed promptly.

Q: What is the maximum amount of time X-Cam is typically used for?

A: Regulatory guidelines stress the importance of using the lowest effective dose for the shortest duration possible. This measure is advised to minimize the risk of serious side effects. Official documentation does not provide a single explicit maximum time limit for all approved uses.

Q: Why do some people report feeling tired after taking X-Cam?

A: Official safety data lists adverse reactions that include lethargy (a lack of energy) and fatigue as possible effects of the medicine. These reactions are not classified as very common but are documented in regulatory reports.

Q: Does X-Cam interfere with driving or operating machinery?

A: Regulatory information advises caution because X-Cam is associated with adverse effects like dizziness, somnolence (drowsiness), and visual disturbances. When these effects occur, official labeling recommends caution regarding activities that require concentration, such as driving or operating machinery.

Q: What should be done if an accidental overdose of X-Cam is suspected?

A: Overdose symptoms may include severe drowsiness, stomach pain, vomiting, or lethargy. In severe cases, there is a risk of serious events like acute kidney failure. Suspected overdose requires immediate emergency medical attention.

Q: Is it possible to become dependent on X-Cam?

A: No. X-Cam is an NSAID and, unlike opioid painkillers, it does not have the addictive potential or risk of physical dependence. The medicine works by reducing inflammation and pain.

Q: Does X-Cam interact with caffeine?

A: Caffeine is not listed as having a formal, classified drug-drug interaction with X-Cam in official regulatory documents. However, patient educational resources sometimes caution that caffeine may worsen the risk of gastrointestinal irritation, which is a known risk with X-Cam.

Q: What are the common signs of an allergic reaction to X-Cam?

A: Official labeling warns of the risk of serious allergic reactions, known as anaphylaxis. Common signs may include difficulty breathing, swelling of the face, tongue, or throat, or the presence of hives. These symptoms are indicative of a medical emergency and require immediate care.

Q: Has the FDA issued any recent warnings about X-Cam?

A: Official FDA labeling includes Boxed Warnings (the strongest type of warning) concerning the potential for serious Cardiovascular Thrombotic Events (like heart attack or stroke) and serious Gastrointestinal Adverse Events (like bleeding or ulcers). These serious warnings are regularly reviewed and updated in the official documentation.

Q: Can X-Cam affect mood or cause emotional changes?

A: Adverse event reports, which inform regulatory safety profiles, have documented the potential for mood changes or, in rare instances, depressive psychosis in association with this drug. These are rare effects that have typically resolved after stopping the medication.

Q: Are there studies on X-Cam's use in patients with kidney disease?

A: The official product information specifies a need for specific dosing adjustments for patients undergoing hemodialysis, and it is contraindicated in those with severe, non-dialyzed kidney failure. These restrictions are based on clinical experience and evidence concerning the drug’s potential for renal toxicity in these populations.

Q: What kind of follow-up is generally recommended after starting X-Cam?

A: Official labeling advises monitoring for the drug’s serious risks, especially during prolonged use or when used with interacting medicines. Follow-up typically involves checks of blood pressure, kidney function, and liver function to detect any adverse changes early.

Q: Does taking X-Cam affect the results of common lab tests?

A: Regulatory documents indicate the drug carries a risk of impacting liver enzyme levels and renal function (kidney function). These effects are detectable through routine blood and urine laboratory tests.

Q: Is there a generic version of X-Cam available?

A: Yes. X-Cam is the brand name for the active ingredient meloxicam. Official drug product databases confirm that generic meloxicam is widely available in several authorized formulations.

Q: Are there different strengths of X-Cam available?

A: Yes. According to official regulatory documents, the oral tablets are typically supplied in 7.5 mg and 15 mg strengths. The medicine is also available in different formulations, such as liquid oral suspension and solutions for injection.

Q: Can X-Cam cause problems with liver function?

A: Yes. Official safety information warns of a risk of elevated liver enzyme levels and, in rare instances, serious liver reactions. The medicine is contraindicated in patients with severe hepatic (liver) failure. Regulatory documents indicate that the drug must be stopped if laboratory tests show persistent or worsening signs of liver problems.

Q: Can X-Cam be taken with vitamins or herbal supplements?

A: Official labeling provides a specific caution against combining X-Cam with herbal products that have antiplatelet properties (such as Ginkgo Biloba) due to an increased bleeding risk. Reviewing all vitamins and supplements with a healthcare professional helps check for potential interactions.

How should X-Cam be stored and disposed of?

How to Store and Dispose of X-Cam?

The storage of X-Cam (meloxicam) is strictly defined by regulatory requirements to maintain product stability. The medicine must be kept at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions up to 30 C.


Storage Requirements

X-Cam must be stored in a tight container, in a dry place, and protected from light. It is essential to keep from freezing and store the medication out of the reach of children.


Disposal Instructions

Unused or expired X-Cam must be disposed of according to local regulations. Regulatory guidance recommends using a medicine take-back program. The product must not be flushed down the toilet or poured down a drain unless specifically advised by a local regulatory program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of X-Cam found in:

A-Z Index: